Literature DB >> 21132069

Interferon-gamma inhibits adenosine A2A receptor function in hepatic stellate cells by STAT1-mediated repression of adenylyl cyclase.

Eric T Block1, Bruce N Cronstein.   

Abstract

BACKGROUND AND
PURPOSE: Adenosine, an endogenous purine nucleoside, is a potent regulator of the inflammatory response and stimulus for fibrosis. We have previously demonstrated that adenosine, acting at the A2A receptor, plays a central role in hepatic fibrosis via direct promotion of collagen production by hepatic stellate cells. As we have previously demonstrated that macrophage A2A receptor function is regulated by interferon-gamma (IFNγ), a noted antifibrotic but pro-inflammatory cytokine, we examined its effect on A2AR-stimulated collagen production in the human hepatic stellate cell line LX-2. EXPERIMENTAL APPROACH: Collagen expression was determined by western blotting and realtime reverse transcription polymerase chain reaction (RT-PCR). Receptor desensitization was assessed by western blotting for membrane associated GRK2. Receptor signaling was determined by western blotting for phosphorylated extracellular signal-related protein kinase (ERK) protein and immunoassay for intracellular cyclic AMP (cAMP). siRNA was used to knock down expression of adenylyl cyclase and signal transducer and activator of transcription (STAT). Adenylyl cyclase expression was assessed by realtime RT-PCR, and STAT expression was assessed by western blotting. KEY
RESULTS: IFNγ diminishes A2A receptor-mediated collagen production at both protein and mRNA levels. IFNγ alters signal transduction at A2A receptors by a STAT1 mediated mechanism involving the suppression of adenylyl cyclase expression. CONCLUSIONS AND IMPLICATIONS: IFNγ inhibits the function of the adenosine A2A receptor in hepatic stellate cells by downregulating the expression of adenylyl cyclase. This finding explains, at least in part, the protective effect of IFNγ in hepatic fibrosis.

Entities:  

Year:  2010        PMID: 21132069      PMCID: PMC2995453          DOI: 10.2147/ijicmr.s8860

Source DB:  PubMed          Journal:  Int J Interferon Cytokine Mediat Res        ISSN: 1179-139X


  40 in total

Review 1.  Higher-order organization and regulation of adenylyl cyclases.

Authors:  Dermot M F Cooper; Andrew J Crossthwaite
Journal:  Trends Pharmacol Sci       Date:  2006-07-03       Impact factor: 14.819

2.  Heterodimers of adenylyl cyclases 2 and 5 show enhanced functional responses in the presence of Galpha s.

Authors:  Alessandra Baragli; Maria-Laura Grieco; Phan Trieu; Louis R Villeneuve; Terence E Hébert
Journal:  Cell Signal       Date:  2007-11-22       Impact factor: 4.315

3.  Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma.

Authors:  E S L Chan; P Fernandez; A A Merchant; M C Montesinos; S Trzaska; A Desai; C F Tung; D N Khoa; M H Pillinger; A B Reiss; M Tomic-Canic; J F Chen; M A Schwarzschild; B N Cronstein
Journal:  Arthritis Rheum       Date:  2006-08

4.  Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-beta1 expression in pig serum-induced rat liver fibrosis in vivo.

Authors:  I Sakaida; K Uchida; Y Matsumura; K Okita
Journal:  J Hepatol       Date:  1998-03       Impact factor: 25.083

5.  Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis.

Authors:  Edwin S L Chan; Maria Carmen Montesinos; Patricia Fernandez; Avani Desai; David L Delano; Herman Yee; Allison B Reiss; Michael H Pillinger; Jiang-Fan Chen; Michael A Schwarzschild; Scott L Friedman; Bruce N Cronstein
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

6.  STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.

Authors:  Won-Il Jeong; Ogyi Park; Svetlana Radaeva; Bin Gao
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

7.  Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: role of A2B receptors.

Authors:  R K Dubey; D G Gillespie; E K Jackson
Journal:  Hypertension       Date:  1998-04       Impact factor: 10.190

8.  Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages.

Authors:  Allison B Reiss; Mohammad M Rahman; Edwin S L Chan; M Carmen Montesinos; Nahel W Awadallah; Bruce N Cronstein
Journal:  J Leukoc Biol       Date:  2004-06-14       Impact factor: 4.962

9.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

10.  Selective coupling of type 6 adenylyl cyclase with type 2 IP3 receptors mediates direct sensitization of IP3 receptors by cAMP.

Authors:  Stephen C Tovey; Skarlatos G Dedos; Emily J A Taylor; Jarrod E Church; Colin W Taylor
Journal:  J Cell Biol       Date:  2008-10-20       Impact factor: 10.539

View more
  3 in total

Review 1.  Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.

Authors:  Bruce N Cronstein; Michail Sitkovsky
Journal:  Nat Rev Rheumatol       Date:  2016-11-10       Impact factor: 20.543

Review 2.  Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness.

Authors:  Valentina Bova; Alessia Filippone; Giovanna Casili; Marika Lanza; Michela Campolo; Anna Paola Capra; Alberto Repici; Lelio Crupi; Gianmarco Motta; Cristina Colarossi; Giulia Chisari; Salvatore Cuzzocrea; Emanuela Esposito; Irene Paterniti
Journal:  Cancers (Basel)       Date:  2022-08-20       Impact factor: 6.575

Review 3.  Drugs and Targets in Fibrosis.

Authors:  Xiaoyi Li; Lixin Zhu; Beibei Wang; Meifei Yuan; Ruixin Zhu
Journal:  Front Pharmacol       Date:  2017-11-23       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.